Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.
Market Data
Essential tool: analyze, trade, manage, decide.
What’s Your Call?
Collective community sentiment on Sudarshan Pharma Industries Ltd
Your Vote -
Buy
33.33%
Hold
33.33%
Sell
33.33%
33.33%
3 users have voted
Option Chain
Analyzes market sentiment, predicts Sudarshan Pharma Industries Ltd' movement.
NO_RECORD_FOUND
News
Media spotlight triggers stock stock attention, sentiment.
-
Sudarshan Pharma - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
-
Sudarshan Pharma - Revision Of Disclosure Made By The Company Under Paragraph 2.1(F) Of The Master Circular Compliance With T
-
Sudarshan Pharma - Outcome Of Board Meeting Held Today I.E. Thursday, 21St May 2026
-
Sudarshan Pharma - Announcement under Regulation 30 (LODR)-Allotment
-
Sudarshan Pharma - Update on board meeting
-
Sudarshan Pharma - Board Meeting Intimation for Meeting Of The Board Of Directors Of The Company Scheduled To Be Held On Frid
-
Sudarshan Pharma - Email By BSE Seeking Additional Details Required For Corporate Announcement Filed Under Regulation 30 Of S
-
Sudarshan Pharma - Announcement under Regulation 30 (LODR)-Investor Presentation
-
Sudarshan Pharma - Board Meeting Outcome for Approval Of Upto U.S. $ 20,000,000 Of 8.00% Senior Unsecured Foreign Currency Co
-
Sudarshan Pharma - Board Meeting Intimation for Meeting To Be Held On Friday, May 15, 2026
-
Sudarshan Pharma - Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)
-
Sudarshan Pharma Q4 net profit up 35.70% at Rs 9.54 cr
-
Sudarshan Pharma - Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)
-
Sudarshan Pharma - Board Meeting Intimation for Meeting Scheduled On Thursday, April 30, 2026
-
Sudarshan Pharma has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2026
-
Sudarshan Pharma - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Key fundamentals
Evaluate the intrinsic value of Sudarshan Pharma Industries Ltd stock
| Name | March-25 | March-24 | March-23 | March-22 | March-21 |
|---|---|---|---|---|---|
| Assets | 304.2687 | 218.505 | 135.0755 | 60.3629 | 52.279 |
| Liabilities | 304.2687 | 218.505 | 135.0755 | 60.3629 | 52.279 |
| Equity | 24.0659 | 24.0659 | 24.0659 | 9.749 | 9.5469 |
| Gross Profit | 38.5027 | 22.6045 | 14.6916 | 10.92 | 7.1839 |
| Net Profit | 15.877 | 11.3553 | 7.0398 | 5.2524 | 2.6726 |
| Cash From Operating Activities | 34.906 | 7.9492 | -28.7907 | -3.7022 | 2.6746 |
| NPM(%) | 3.15 | 2.43 | 1.52 | 1.47 | 1.38 |
| Revenue | 502.5065 | 465.5623 | 461.3319 | 357.0946 | 193.3503 |
| Expenses | 464.0038 | 442.9578 | 446.6403 | 346.1746 | 186.1663 |
| ROE(%) | 11.01 | 7.88 | 4.88 | 3.64 | 1.85 |
Corporate Action
| XD-Date | Dividend-Amount | Dividend-% | Dividend Yield(%GE) | Price on that day |
|---|
Peers
Other companies within the same industry or sector that are comparable to Sudarshan Pharma Industries Ltd
| Company | Price | Price (% change) | pe(x) | EV/EBITDA(x) | ROE(%) | ROCE(%) |
|---|---|---|---|---|---|---|
| Albert David Ltd | 721.75 | 0.85 | 0.00 | 20.24 | -26.19 | 0.70 |
| Lotus Eye Hospital and Institute Ltd | 108.90 | -1.89 | 3610.00 | 73.76 | 3.55 | 0.00 |
| Bharat Immunological and Biologicals Corporation Ltd | 17.53 | 1.10 | 0.00 | 153.16 | -39.50 | 0.00 |
| Astec Lifesciences Ltd | 753.50 | 1.24 | 0.00 | 69.56 | -363.15 | 0.00 |
Company Info
The Company was originally incorporated on July 23, 2008 as a Private Limited Company as "Sudarshan Speciality Chemsolve Private Limited" under the provisions of the Companies Act, 1956 with the Registrar of Companies, Mumbai. Later in the year 2016, the name of the company was changed from "Sudarshan Specialty Chemsolve Private Limited" to "Sudarshan Pharma Industries Private Limited" under the Companies Act, 2013 pursuant to a special resolution passed by our shareholders at the EGM held on November 25, 2016 and vide certificate of incorporation dated December 17, 2016 issued by the Registrar of Companies, Mumbai. Subsequently, pursuant to a Special Resolution of our Shareholders passed in the Extra-Ordinary General Meeting held on December 12, 2016 the Company was converted from a Private Limited Company to Public Limited Company and consequently, the name of the Company was changed to `Sudarshan Pharma Industries Limited' and a Fresh Certificate of Incorporation consequent to Conversion was issued on January 05, 2017 by the Registrar of Companies, Mumbai. The Corporate Identification Number of the Company is U51496MH2008PLC184997.MAJOR EVENTS AND MILESTONES:Year Particulars2008 -Incorporation of the company in the name and style of "Sudarshan Specialty Chemsolve Private Limited"2011 -Generic formulations for institution supply, NGO's and wholesale market2012 -Branded Generic formulations in Maharashtra2013 -Established the footprints in Gujarat, West Bengal, Chhattisgarh and Uttar Pradesh2014 -Introduced brands in New Drug Delivery System2015 -Over 5,000 medical practitioners associated with SPIL2016 -Company's name was changed from "Sudarshan Specialty Chemsolve Private Limited" to "Sudarshan Pharma Industries Private Limited"-7 own branded products introduced successfully in Vimac2017 -Conversion of the Company from Private Limited Company to Public Limited Company and Change of name of Company to Sudarshan Pharma Industries Limited2018 -Brand Brilliance Award from Asian African leadership forum in Pharma2019 -Launch Hart Kit Loading Dose and Hart Kit-42021 -VD-Section Got 50.00 cr. Government order (Started work on CORONA protection) 2024-The Company has splits its face value from Rs. 10/- to Rs. 1/-.2025-The Acquisition of Sudarshan Pharma Industries Private Limited.
The Company was originally incorporated on July 23, 2008 as a Private Limited Company as "Sudarshan Speciality Chemsolve Private Limited" under the provisions of the Companies Act, 1956 with the Registrar of Companies, Mumbai. Later in the year 2016, the name of the company was changed from "Sudarshan Specialty Chemsolve Private Limited" to "Sudarshan Pharma Industries Private Limited" under the Companies Act, 2013 pursuant to a special resolution passed by our shareholders at the EGM held on November 25, 2016 and vide certificate of incorporation dated December 17, 2016 issued by the Registrar of Companies, Mumbai. Subsequently, pursuant to a Special Resolution of our Shareholders passed in the Extra-Ordinary General Meeting held on December 12, 2016 the Company was converted from a Private Limited Company to Public Limited Company and consequently, the name of the Company was changed to `Sudarshan Pharma Industries Limited' and a Fresh Certificate of Incorporation consequent to Conversion was issued on January 05, 2017 by the Registrar of Companies, Mumbai. The Corporate Identification Number of the Company is U51496MH2008PLC184997.MAJOR EVENTS AND MILESTONES:Year Particulars2008 -Incorporation of the company in the name and style of "Sudarshan Specialty Chemsolve Private Limited"2011 -Generic formulations for institution supply, NGO's and wholesale market2012 -Branded Generic formulations in Maharashtra2013 -Established the footprints in Gujarat, West Bengal, Chhattisgarh and Uttar Pradesh2014 -Introduced brands in New Drug Delivery System2015 -Over 5,000 medical practitioners associated with SPIL2016 -Company's name was changed from "Sudarshan Specialty Chemsolve Private Limited" to "Sudarshan Pharma Industries Private Limited"-7 own branded products introduced successfully in Vimac2017 -Conversion of the Company from Private Limited Company to Public Limited Company and Change of name of Company to Sudarshan Pharma Industries Limited2018 -Brand Brilliance Award from Asian African leadership forum in Pharma2019 -Launch Hart Kit Loading Dose and Hart Kit-42021 -VD-Section Got 50.00 cr. Government order (Started work on CORONA protection) 2024-The Company has splits its face value from Rs. 10/- to Rs. 1/-.2025-The Acquisition of Sudarshan Pharma Industries Private Limited.
Read More
Parent Organisation
Sudarshan Pharma Industries Ltd.
Founded
23/07/2008
Managing Director
Mr.Hemal Vasantrai Mehta
NSE Symbol
FAQ
The current price of Sudarshan Pharma Industries Ltd is
The 52-week high for Sudarshan Pharma Industries Ltd is
The market capitalization of Sudarshan Pharma Industries Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.
To buy Sudarshan Pharma Industries Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.
To invest in Sudarshan Pharma Industries Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Sudarshan Pharma Industries Ltd shares.
The CEO of Sudarshan Pharma Industries Ltd is Mr.Hemal Vasantrai Mehta, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.
